SUPER-REFRACTORY STATUS EPILEPTICUS
Clinical trials for SUPER-REFRACTORY STATUS EPILEPTICUS explained in plain language.
Never miss a new study
Get alerted when new SUPER-REFRACTORY STATUS EPILEPTICUS trials appear
Sign up with your email to follow new studies for SUPER-REFRACTORY STATUS EPILEPTICUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Stop seizures? early trial tests SAGE-547
Disease control CompletedThis study tested a drug called SAGE-547 in 25 people aged 2 and older who were having a severe, life-threatening seizure that did not stop with standard treatments. The main goal was to see if the drug was safe and tolerable. The study was completed, but results are not yet avai…
Matched conditions: SUPER-REFRACTORY STATUS EPILEPTICUS
Phase: PHASE1, PHASE2 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 18, 2026 11:47 UTC
-
Breakthrough drug may free patients from Life-Threatening seizure coma
Disease control CompletedThis study tested an experimental drug called SAGE-547 in 132 people with super-refractory status epilepticus, a life-threatening condition where seizures do not stop even with strong emergency medicines. The goal was to see if SAGE-547 could help patients safely come off those e…
Matched conditions: SUPER-REFRACTORY STATUS EPILEPTICUS
Phase: PHASE3 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 17, 2026 12:02 UTC